EP-1350 DART-bid by VMAT for locally advanced NSCLC: Low toxicity, encouraging survival and tumor control

Autor: Wurstbauer, K., Pinter, R., Meinschad, M., Kazil, M., Hernler, T., Cerkl, P., Künzler, T., De Vries, A.
Zdroj: In Radiotherapy and Oncology April 2019 133 Supplement 1:S738-S739
Databáze: ScienceDirect